View Future GrowthOrchasp 過去の業績過去 基準チェック /36Orchaspの収益は年間平均-33.4%の割合で減少していますが、 Software業界の収益は年間 増加しています。収益は年間16.8% 3.1%割合で 減少しています。 Orchaspの自己資本利益率は3.5%であり、純利益率は15.1%です。主要情報-33.36%収益成長率-27.71%EPS成長率Software 業界の成長22.64%収益成長率-3.07%株主資本利益率3.51%ネット・マージン15.12%次回の業績アップデート27 May 2026最近の業績更新お知らせ • May 18Orchasp Limited to Report Q4, 2026 Results on May 27, 2026Orchasp Limited announced that they will report Q4, 2026 results on May 27, 2026Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.013 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.01 (down from ₹0.013 in 3Q 2025). Revenue: ₹43.8m (down 27% from 3Q 2025). Net income: ₹1.90m (down 62% from 3Q 2025). Profit margin: 4.3% (down from 8.3% in 3Q 2025). The decrease in margin was driven by lower revenue.お知らせ • Feb 01Orchasp Limited to Report Q3, 2026 Results on Feb 10, 2026Orchasp Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 10, 2026Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.37 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.01 (up from ₹0.37 loss in 2Q 2025). Revenue: ₹75.6m (up 65% from 2Q 2025). Net income: ₹2.08m (up ₹144.8m from 2Q 2025). Profit margin: 2.7% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue.お知らせ • Oct 28Orchasp Limited to Report Q2, 2026 Results on Nov 11, 2025Orchasp Limited announced that they will report Q2, 2026 results on Nov 11, 2025Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.007 in 1Q 2025)First quarter 2026 results: EPS: ₹0.02 (up from ₹0.007 in 1Q 2025). Revenue: ₹77.5m (up 123% from 1Q 2025). Net income: ₹5.42m (up 138% from 1Q 2025). Profit margin: 7.0% (up from 6.6% in 1Q 2025). The increase in margin was driven by higher revenue.すべての更新を表示Recent updatesお知らせ • May 18Orchasp Limited to Report Q4, 2026 Results on May 27, 2026Orchasp Limited announced that they will report Q4, 2026 results on May 27, 2026Valuation Update With 7 Day Price Move • Mar 11Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₹2.03, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 25x in the Software industry in India. Total loss to shareholders of 30% over the past year.New Risk • Feb 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (₹262m revenue, or US$2.9m). Market cap is less than US$100m (₹920.3m market cap, or US$10.1m).Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.013 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.01 (down from ₹0.013 in 3Q 2025). Revenue: ₹43.8m (down 27% from 3Q 2025). Net income: ₹1.90m (down 62% from 3Q 2025). Profit margin: 4.3% (down from 8.3% in 3Q 2025). The decrease in margin was driven by lower revenue.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹2.39, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 33x in the Software industry in India. Total loss to shareholders of 33% over the past year.お知らせ • Feb 01Orchasp Limited to Report Q3, 2026 Results on Feb 10, 2026Orchasp Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 10, 2026お知らせ • Dec 19Orchasp Limited announced that it expects to receive INR 86 million in fundingOrchasp Limited in its Board Meeting announced a private placement of 26,875,000 Common Shares of the company at a price per share of INR 3.20 for gross proceeds of INR 86,000,000 on preferential basis on December 18, 2025. The transaction includes participation from individual investor Mrs. P. Rajeswari.Buy Or Sell Opportunity • Dec 18Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 6.0% to ₹2.84. The fair value is estimated to be ₹2.29, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.Buy Or Sell Opportunity • Nov 25Now 24% overvaluedOver the last 90 days, the stock has fallen 2.7% to ₹2.88. The fair value is estimated to be ₹2.32, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.New Risk • Nov 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹850.0m (US$9.49m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Market cap is less than US$10m (₹850.0m market cap, or US$9.49m). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Revenue is less than US$5m (₹283m revenue, or US$3.2m).分析記事 • Nov 21Does Orchasp (NSE:ORCHASP) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.37 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.01 (up from ₹0.37 loss in 2Q 2025). Revenue: ₹75.6m (up 65% from 2Q 2025). Net income: ₹2.08m (up ₹144.8m from 2Q 2025). Profit margin: 2.7% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue.お知らせ • Oct 28Orchasp Limited to Report Q2, 2026 Results on Nov 11, 2025Orchasp Limited announced that they will report Q2, 2026 results on Nov 11, 2025New Risk • Oct 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 66% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Revenue is less than US$5m (₹254m revenue, or US$2.9m). Market cap is less than US$100m (₹1.20b market cap, or US$13.6m).お知らせ • Sep 01Orchasp Limited, Annual General Meeting, Sep 30, 2025Orchasp Limited, Annual General Meeting, Sep 30, 2025, at 10:30 Indian Standard Time.Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.007 in 1Q 2025)First quarter 2026 results: EPS: ₹0.02 (up from ₹0.007 in 1Q 2025). Revenue: ₹77.5m (up 123% from 1Q 2025). Net income: ₹5.42m (up 138% from 1Q 2025). Profit margin: 7.0% (up from 6.6% in 1Q 2025). The increase in margin was driven by higher revenue.New Risk • Jul 28New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 67% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$9.92m). Minor Risk Revenue is less than US$5m (₹211m revenue, or US$2.4m).お知らせ • Jul 28Orchasp Limited to Report Q1, 2026 Results on Aug 11, 2025Orchasp Limited announced that they will report Q1, 2026 results on Aug 11, 2025Reported Earnings • May 29Full year 2025 earnings released: ₹0.42 loss per share (vs ₹0.045 profit in FY 2024)Full year 2025 results: ₹0.42 loss per share (down from ₹0.045 profit in FY 2024). Revenue: ₹216.2m (up 63% from FY 2024). Net loss: ₹105.2m (down ₹112.0m from profit in FY 2024).お知らせ • May 19Orchasp Limited to Report Q4, 2025 Results on May 28, 2025Orchasp Limited announced that they will report Q4, 2025 results on May 28, 2025New Risk • Mar 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 68% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$10.00m). Minor Risk Revenue is less than US$5m (₹176m revenue, or US$2.0m).Board Change • Feb 10Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Ravikishore Vithaleswara Bhattiprolu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.収支内訳Orchasp の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NSEI:ORCHASP 収益、費用、利益 ( )INR Millions日付収益収益G+A経費研究開発費31 Dec 25262402030 Sep 25283432030 Jun 25254-1020031 Mar 25211-1052031 Dec 24176-1352030 Sep 24148-1402030 Jun 2413770031 Mar 2413272031 Dec 23195-103030 Sep 23207-13030 Jun 2321900031 Mar 2323543031 Dec 22234132030 Jun 2233342031 Mar 2237312031 Dec 21370212030 Jun 21178100031 Mar 219322031 Dec 20259-262030 Jun 20666-42031 Mar 20828172031 Dec 19801462030 Sep 19705502030 Jun 19648570031 Mar 19604622031 Dec 1848062424030 Sep 1846756424030 Jun 18540500031 Mar 181,047382031 Dec 171,40829115030 Sep 171,31429115030 Jun 171,16831115031 Mar 1753523115031 Dec 16122-675127030 Sep 16131-668127030 Jun 16128-674127031 Mar 16135-672144031 Dec 15140-2809030 Sep 15135-2869030 Jun 15130-28790質の高い収益: ORCHASPは 高品質の収益 を持っています。利益率の向上: ORCHASP過去に利益を上げました。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: ORCHASP過去 5 年間で収益を上げており、収益は年間-33.4%増加しています。成長の加速: ORCHASPは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。収益対業界: ORCHASP昨年収益を上げたため、昨年の収益成長をSoftware業界 ( 8.7% ) と比較することは困難です。株主資本利益率高いROE: ORCHASPの 自己資本利益率 ( 3.5% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YSoftware 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/20 03:01終値2026/05/20 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Orchasp Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 18Orchasp Limited to Report Q4, 2026 Results on May 27, 2026Orchasp Limited announced that they will report Q4, 2026 results on May 27, 2026
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.013 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.01 (down from ₹0.013 in 3Q 2025). Revenue: ₹43.8m (down 27% from 3Q 2025). Net income: ₹1.90m (down 62% from 3Q 2025). Profit margin: 4.3% (down from 8.3% in 3Q 2025). The decrease in margin was driven by lower revenue.
お知らせ • Feb 01Orchasp Limited to Report Q3, 2026 Results on Feb 10, 2026Orchasp Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 10, 2026
Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.37 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.01 (up from ₹0.37 loss in 2Q 2025). Revenue: ₹75.6m (up 65% from 2Q 2025). Net income: ₹2.08m (up ₹144.8m from 2Q 2025). Profit margin: 2.7% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue.
お知らせ • Oct 28Orchasp Limited to Report Q2, 2026 Results on Nov 11, 2025Orchasp Limited announced that they will report Q2, 2026 results on Nov 11, 2025
Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.007 in 1Q 2025)First quarter 2026 results: EPS: ₹0.02 (up from ₹0.007 in 1Q 2025). Revenue: ₹77.5m (up 123% from 1Q 2025). Net income: ₹5.42m (up 138% from 1Q 2025). Profit margin: 7.0% (up from 6.6% in 1Q 2025). The increase in margin was driven by higher revenue.
お知らせ • May 18Orchasp Limited to Report Q4, 2026 Results on May 27, 2026Orchasp Limited announced that they will report Q4, 2026 results on May 27, 2026
Valuation Update With 7 Day Price Move • Mar 11Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₹2.03, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 25x in the Software industry in India. Total loss to shareholders of 30% over the past year.
New Risk • Feb 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (₹262m revenue, or US$2.9m). Market cap is less than US$100m (₹920.3m market cap, or US$10.1m).
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.013 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.01 (down from ₹0.013 in 3Q 2025). Revenue: ₹43.8m (down 27% from 3Q 2025). Net income: ₹1.90m (down 62% from 3Q 2025). Profit margin: 4.3% (down from 8.3% in 3Q 2025). The decrease in margin was driven by lower revenue.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹2.39, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 33x in the Software industry in India. Total loss to shareholders of 33% over the past year.
お知らせ • Feb 01Orchasp Limited to Report Q3, 2026 Results on Feb 10, 2026Orchasp Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 10, 2026
お知らせ • Dec 19Orchasp Limited announced that it expects to receive INR 86 million in fundingOrchasp Limited in its Board Meeting announced a private placement of 26,875,000 Common Shares of the company at a price per share of INR 3.20 for gross proceeds of INR 86,000,000 on preferential basis on December 18, 2025. The transaction includes participation from individual investor Mrs. P. Rajeswari.
Buy Or Sell Opportunity • Dec 18Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 6.0% to ₹2.84. The fair value is estimated to be ₹2.29, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.
Buy Or Sell Opportunity • Nov 25Now 24% overvaluedOver the last 90 days, the stock has fallen 2.7% to ₹2.88. The fair value is estimated to be ₹2.32, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.
New Risk • Nov 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹850.0m (US$9.49m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Market cap is less than US$10m (₹850.0m market cap, or US$9.49m). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Revenue is less than US$5m (₹283m revenue, or US$3.2m).
分析記事 • Nov 21Does Orchasp (NSE:ORCHASP) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.37 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.01 (up from ₹0.37 loss in 2Q 2025). Revenue: ₹75.6m (up 65% from 2Q 2025). Net income: ₹2.08m (up ₹144.8m from 2Q 2025). Profit margin: 2.7% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue.
お知らせ • Oct 28Orchasp Limited to Report Q2, 2026 Results on Nov 11, 2025Orchasp Limited announced that they will report Q2, 2026 results on Nov 11, 2025
New Risk • Oct 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 66% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Revenue is less than US$5m (₹254m revenue, or US$2.9m). Market cap is less than US$100m (₹1.20b market cap, or US$13.6m).
お知らせ • Sep 01Orchasp Limited, Annual General Meeting, Sep 30, 2025Orchasp Limited, Annual General Meeting, Sep 30, 2025, at 10:30 Indian Standard Time.
Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.007 in 1Q 2025)First quarter 2026 results: EPS: ₹0.02 (up from ₹0.007 in 1Q 2025). Revenue: ₹77.5m (up 123% from 1Q 2025). Net income: ₹5.42m (up 138% from 1Q 2025). Profit margin: 7.0% (up from 6.6% in 1Q 2025). The increase in margin was driven by higher revenue.
New Risk • Jul 28New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 67% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$9.92m). Minor Risk Revenue is less than US$5m (₹211m revenue, or US$2.4m).
お知らせ • Jul 28Orchasp Limited to Report Q1, 2026 Results on Aug 11, 2025Orchasp Limited announced that they will report Q1, 2026 results on Aug 11, 2025
Reported Earnings • May 29Full year 2025 earnings released: ₹0.42 loss per share (vs ₹0.045 profit in FY 2024)Full year 2025 results: ₹0.42 loss per share (down from ₹0.045 profit in FY 2024). Revenue: ₹216.2m (up 63% from FY 2024). Net loss: ₹105.2m (down ₹112.0m from profit in FY 2024).
お知らせ • May 19Orchasp Limited to Report Q4, 2025 Results on May 28, 2025Orchasp Limited announced that they will report Q4, 2025 results on May 28, 2025
New Risk • Mar 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 68% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$10.00m). Minor Risk Revenue is less than US$5m (₹176m revenue, or US$2.0m).
Board Change • Feb 10Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Ravikishore Vithaleswara Bhattiprolu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.